1003879-02-4

Basic information

• Product Name: 2-bromo-1-(4-bromo-3-fluorophenyl)ethanone
• Synonyms: 2-bromo-1-(4-bromo-3-fluorophenyl)ethanone
• CAS NO: 1003879-02-4
• Molecular Formula: C₈H₅Br₂FO
• Molecular Weight: 296
• Mol File: 1003879-02-4.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• Density: 1.914
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-bromo-1-(4-bromo-3-fluorophenyl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-1-(4-bromo-3-fluorophenyl)ethanone(1003879-02-4)
• EPA Substance Registry System: 2-bromo-1-(4-bromo-3-fluorophenyl)ethanone(1003879-02-4)

Safety Data

• Hazardous Substances Data: 1003879-02-4(Hazardous Substances Data)

Usage

General Description

2-bromo-1-(4-bromo-3-fluorophenyl)ethanone is a chemical compound with the molecular formula C8H6Br2FO. It is an organic compound that belongs to the class of ketones. 2-bromo-1-(4-bromo-3-fluorophenyl)ethanone is characterized by the presence of both bromine and fluorine atoms in its structure. It is commonly used in organic synthesis as a building block for the production of various pharmaceuticals and agrochemicals. Its chemical properties and structure make it a versatile compound for use in the pharmaceutical and agrochemical industries.

Upstream product

• 695188-21-7 4-bromo-3-fluorobenzoyl chloride 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 1263483-58-4 2-Diazo-1-(4-bromo-3-fluorophenyl)ethanone 
• 304445-49-6 1-(4-bromo-3-fluorophenyl)ethan-1-one 
• 343564-56-7 4-bromo-3-fluoro-N-methoxy-N-methyl-benzamide 
• 153556-42-4 4-bromo-3-fluorobenzoic acid 

Downstream Products

• 1263483-60-8 3-(4-{1-[4-(4-Bromo-3-fluorophenyl)-1,3-oxazol-2-yl]propoxy}phenyl)-5-isopropyl-1,2,4-oxadiazole 
• 1263483-61-9 2-Fluoro-4-(2-{1-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]propyl}-1,3-oxazol-4-yl)benzoic acid 
• 1263483-59-5 2-(4-Bromo-3-fluorophenyl)-2-oxoethyl 2-[4-(5-isopropyl-1,2,4-oxadiazol-3-yl)phenoxy]butanoate 
• 1335317-38-8 C₄₀H₄₇FN₆O₄S 
• 1335317-43-5 C₄₄H₅₃FN₈O₆S 
• 1447831-82-4 tert-butyl 2-(3-(4-fluorobenzamido)-1H-indazol-6-yl)morpholine-4-carboxylate 
• 1447831-80-2 tert-butyl 2-(4-cyano-3-fluorophenyl)morpholine-4-carboxylate 
• 1400997-38-7 (RS)-2-(4-bromo-3-fluorophenyl)-morpholine-4-carboxylic acid tert-butyl ester 
• 1400997-37-6 (RS)-[2-(4-bromo-3-fluorophenyl)-2-hydroxyethyl]-(2-hydroxyethyl)carbamic acid tert-butyl ester 
• 1400997-36-5 (RS)-1-(4-bromo-3-fluorophenyl)-2-(2-hydroxyethylamino)-ethanol 
• 1400997-35-4 (RS)-2-(4-bromo-3-fluorophenyl)-oxirane 

Relevant articles and documents

HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS

A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.

Bridged Ring compounds As Hepatitis C Virus (HCV) Inhibitors And Pharmaceutical Applications Thereof

Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.

BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF

Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.